Editorial: Targeting the Immune System to Treat Hepatitis B Virus Infection

Front Immunol. 2022 Mar 15:13:868616. doi: 10.3389/fimmu.2022.868616. eCollection 2022.

Zhongji Meng¹, Jia Liu², Anna D Kosinska^{3

4}, Mengji Lu⁵

¹ Institute of Biomedical Research, Hubei Clinical Research Center for Precise Diagnosis and Therapy of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
² Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Institute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
⁴ German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.
⁵ Institute of Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.

No abstract available

Keywords: Immune response; T cell therapy; hepatitis B Virus; immune tolerance; immunotherapy; innate immunity; therapeutic vaccine.

Publication types